Literature DB >> 25962969

Therapeutic Basis of Clinical Pain Modulation.

Daniel R Kirkpatrick1, Dan M McEntire1, Zakary J Hambsch1, Mitchell J Kerfeld1, Tyler A Smith1, Mark D Reisbig1, Charles F Youngblood1, Devendra K Agrawal1.   

Abstract

Pain is a hallmark of almost all bodily ailments and can be modulated by agents, including analgesics and anesthetics that suppress pain signals in the central nervous system. Defects in the modulatory systems, including the endogenous pain-inhibitory pathways, are a major factor in the initiation and chronicity of pain. Thus, pain modulation is particularly applicable to the practice of medicine. This review summarizes the existing literature on pain modulation. Here, we critically reviewed the literature from PubMed on pain modulation published primarily within the past 5 years in high impact journals. Specifically, we have discussed important anatomical landmarks of pain modulation and outlined the endogenous networks and underlying mechanisms of clinically relevant pain modulatory methods. The Gate Control Theory is briefly presented with discussion on the capacity of pain modulation to cause both hyper- and hypoalgesia. An emphasis has been given to highlight key areas in pain research that, because of unanswered questions or therapeutic potential, merit additional scientific scrutiny. The information presented in this paper would be helpful in developing novel therapies, metrics, and interventions for improved patient management.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Gate Control Theory; cannabinoids; electroanalgesia; inhibitory amino acids; opioids; pain modulation; periaqueductal gray; rostral ventromedial medulla

Mesh:

Substances:

Year:  2015        PMID: 25962969      PMCID: PMC4641846          DOI: 10.1111/cts.12282

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  74 in total

1.  The association between polymorphisms in serotonin-related genes and pain modulation might be of importance for the pathogenesis of sudden infant death syndrome.

Authors:  Michael Klintschar
Journal:  J Pain       Date:  2012-05       Impact factor: 5.820

Review 2.  Efficacy of antidepressants as analgesics: a review.

Authors:  Pinky Dharmshaktu; Vandana Tayal; Bhupinder Singh Kalra
Journal:  J Clin Pharmacol       Date:  2011-03-17       Impact factor: 3.126

3.  Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain.

Authors:  H L Rittner; A Brack; H Machelska; S A Mousa; M Bauer; M Schäfer; C Stein
Journal:  Anesthesiology       Date:  2001-08       Impact factor: 7.892

4.  A question of balance--positive versus negative allosteric modulation of GABA(A) receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain.

Authors:  Gordon Munro; Helle K Erichsen; Mark G Rae; Naheed R Mirza
Journal:  Neuropharmacology       Date:  2011-03-31       Impact factor: 5.250

5.  Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior.

Authors:  Zhen Li; Guangchen Ji; Volker Neugebauer
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

6.  Functional magnetic resonance imaging of the effects of low-frequency transcutaneous electrical nerve stimulation on central pain modulation: a double-blind, placebo-controlled trial.

Authors:  Figen Kocyigit; Elif Akalin; Naciye Sinem Gezer; Ozge Orbay; Ali Kocyigit; Emel Ada
Journal:  Clin J Pain       Date:  2012-09       Impact factor: 3.442

7.  Alternating-frequency TENS effects on experimental pain in healthy human participants: a randomized placebo-controlled trial.

Authors:  Leica S Claydon; Linda S Chesterton; Panos Barlas; Julius Sim
Journal:  Clin J Pain       Date:  2013-06       Impact factor: 3.442

8.  Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered 'wanting' for reward: entire core and medial shell mapped as substrates for PIT enhancement.

Authors:  Susana Peciña; Kent C Berridge
Journal:  Eur J Neurosci       Date:  2013-03-17       Impact factor: 3.386

9.  Peripheral galanin receptor 2 as a target for the modulation of pain.

Authors:  Richard P Hulse; Lucy F Donaldson; David Wynick
Journal:  Pain Res Treat       Date:  2012-01-24

10.  Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.

Authors:  Wei Xiong; Tanxing Cui; Kejun Cheng; Fei Yang; Shao-Rui Chen; Dan Willenbring; Yun Guan; Hui-Lin Pan; Ke Ren; Yan Xu; Li Zhang
Journal:  J Exp Med       Date:  2012-05-14       Impact factor: 14.307

View more
  11 in total

Review 1.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

2.  Updated Review of Fish Analgesia.

Authors:  Frederic Chatigny; Catherine M Creighton; E Don Stevens
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-01-01       Impact factor: 1.232

Review 3.  Current and Future Perspective of Devices and Diagnostics for Opioid and OIRD.

Authors:  Naveen K Singh; Gurpreet K Sidhu; Kuldeep Gupta
Journal:  Biomedicines       Date:  2022-03-22

Review 4.  Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and Clinical Pain.

Authors:  Janie Damien; Luana Colloca; Carmen-Édith Bellei-Rodriguez; Serge Marchand
Journal:  Int Rev Neurobiol       Date:  2018-08-14       Impact factor: 3.230

Review 5.  Endogenous opioid system: a promising target for future smoking cessation medications.

Authors:  Haval Norman; Manoranjan S D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-11       Impact factor: 4.530

Review 6.  Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.

Authors:  Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2016-03-30       Impact factor: 4.530

Review 7.  Complementary and alternative medicine therapies for chronic pain.

Authors:  Brent A Bauer; Jon C Tilburt; Amit Sood; Guang-Xi Li; Shi-Han Wang
Journal:  Chin J Integr Med       Date:  2016-05-26       Impact factor: 1.978

8.  The possible mechanisms of protocatechuic acid-induced central analgesia.

Authors:  Rana Arslan; Sule Aydin; Dilara Nemutlu Samur; Nurcan Bektas
Journal:  Saudi Pharm J       Date:  2018-02-02       Impact factor: 4.330

Review 9.  An Insight and Update on the Analgesic Properties of Vitamin C.

Authors:  Nallan Csk Chaitanya; Arvind Muthukrishnan; C M S Krishnaprasad; Gali Sanjuprasanna; Poojaragini Pillay; Balmoori Mounika
Journal:  J Pharm Bioallied Sci       Date:  2018 Jul-Sep

10.  Practical approach to a patient with chronic pain of uncertain etiology in primary care.

Authors:  Shaquir Salduker; Eugene Allers; Sudha Bechan; R Eric Hodgson; Fanie Meyer; Helgard Meyer; Johan Smuts; Eileen Vuong; David Webb
Journal:  J Pain Res       Date:  2019-09-03       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.